SNOVI HEALTH PRODUCTS INC – Trademark Portfolio

Entity Type: 03

SNOVI HEALTH PRODUCTS INC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include WYEXPRESS and DECHIPRINE. The owner is based in Flushing, NY.

3907 Prince Street, Suite 6B

Flushing, NY 11354

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WYEXPRESS
WYEXPRESS
Registered 2022
SNOVI
SNOVI
Abandoned 2018

Trademark Classifications

SNOVI HEALTH PRODUCTS INC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SNOVI HEALTH PRODUCTS INC have?

SNOVI HEALTH PRODUCTS INC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does SNOVI HEALTH PRODUCTS INC file in?

SNOVI HEALTH PRODUCTS INC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are SNOVI HEALTH PRODUCTS INC's most well-known trademarks?

SNOVI HEALTH PRODUCTS INC's registered trademark portfolio includes well-known marks such as WYEXPRESS and DECHIPRINE. These are among 2 currently registered trademarks in the portfolio.

What is SNOVI HEALTH PRODUCTS INC's trademark registration success rate?

SNOVI HEALTH PRODUCTS INC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.